Cormedix (STU:19KA) Current Accrued Expense : €28.01 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Cormedix Current Accrued Expense?

Cormedix's Current Accrued Expense for the quarter that ended in Mar. 2025 was €28.01 Mil.

Cormedix's quarterly Current Accrued Expense increased from Sep. 2024 (€13.49 Mil) to Dec. 2024 (€28.60 Mil) but then declined from Dec. 2024 (€28.60 Mil) to Mar. 2025 (€28.01 Mil).

Cormedix's annual Current Accrued Expense increased from Dec. 2022 (€3.75 Mil) to Dec. 2023 (€6.39 Mil) and increased from Dec. 2023 (€6.39 Mil) to Dec. 2024 (€28.60 Mil).

Cormedix Current Accrued Expense Historical Data

The historical data trend for Cormedix's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cormedix Current Accrued Expense Chart

Cormedix Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Accrued Expense

Get a 7-Day Free Trial

2.40

2.67

3.75

6.39

28.60

Cormedix Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Current Accrued Expense	Get a 7-Day Free Trial															4.19	5.21	13.49	28.60	28.01

Cormedix Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Cormedix Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Cormedix's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cormedix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (STU:19KA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CRMD:USA

Address

300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922

Website

https://www.cormedix.com

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Cormedix Headlines

No Headlines